Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Benjamin N Rome, M.D.

Co-Author

This page shows the publications co-authored by Benjamin Rome and Aaron Kesselheim.
Connection Strength

14.549
  1. Trends in Prescription Drug Launch Prices, 2008-2021. JAMA. 2022 06 07; 327(21):2145-2147.
    View in: PubMed
    Score: 0.979
  2. Raising Medicaid Rebates For Drugs With Accelerated Approval. Health Aff (Millwood). 2021 12; 40(12):1935-1942.
    View in: PubMed
    Score: 0.945
  3. Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic. J Gen Intern Med. 2021 12; 36(12):3918-3921.
    View in: PubMed
    Score: 0.933
  4. Association of California's Prescription Drug Coupon Ban With Generic Drug Use. JAMA. 2021 06 15; 325(23):2399-2402.
    View in: PubMed
    Score: 0.915
  5. Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017. Value Health. 2021 06; 24(6):804-811.
    View in: PubMed
    Score: 0.906
  6. Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: A population-based cohort study. Am Heart J. 2021 03; 233:109-121.
    View in: PubMed
    Score: 0.889
  7. Transferrable Market Exclusivity Extensions to Promote Antibiotic Development: An Economic Analysis. Clin Infect Dis. 2020 10 23; 71(7):1671-1675.
    View in: PubMed
    Score: 0.875
  8. US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate. JAMA Intern Med. 2020 09 01; 180(9):1165-1172.
    View in: PubMed
    Score: 0.866
  9. Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018. Clin Pharmacol Ther. 2021 02; 109(2):367-371.
    View in: PubMed
    Score: 0.862
  10. Drug Prices, Rebates, and Discounts. JAMA. 2020 07 28; 324(4):399.
    View in: PubMed
    Score: 0.861
  11. US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer Acetate. JAMA Intern Med. 2020 Jul 20.
    View in: PubMed
    Score: 0.859
  12. Federal Spending on Off-Patent Drugs That Lack Generic Competition. J Gen Intern Med. 2021 03; 36(3):821-823.
    View in: PubMed
    Score: 0.837
  13. FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012. JAMA. 2014 Jan 22-29; 311(4):385-91.
    View in: PubMed
    Score: 0.546
  14. Approval of high-risk medical devices in the US: implications for clinical cardiology. Curr Cardiol Rep. 2014; 16(6):489.
    View in: PubMed
    Score: 0.546
  15. Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company. Ann Intern Med. 2022 07; 175(7):1053-1055.
    View in: PubMed
    Score: 0.245
  16. Direct-to-Consumer Generic Drugs: A Maverick Approach or Another Exposure of Market Failures? Ann Intern Med. 2022 06; 175(6):890-891.
    View in: PubMed
    Score: 0.242
  17. Medicaid Spending on Drugs Marketed Without US Food and Drug Administration Approval in 2020. JAMA Intern Med. 2022 03 01; 182(3):342-345.
    View in: PubMed
    Score: 0.240
  18. Payer-Specific Negotiated Prices for Prescription Drugs at Top-Performing US Hospitals. JAMA Intern Med. 2022 01 01; 182(1):83-86.
    View in: PubMed
    Score: 0.238
  19. Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study. BMJ. 2021 09 08; 374:n1959.
    View in: PubMed
    Score: 0.232
  20. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards. Milbank Q. 2021 12; 99(4):1162-1197.
    View in: PubMed
    Score: 0.231
  21. Market Exclusivity and Changes in Competition and Prices Associated With the US Food and Drug Administration Unapproved Drug Initiative. JAMA Intern Med. 2021 08 01; 181(8):1124-1126.
    View in: PubMed
    Score: 0.231
  22. Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States. JAMA Intern Med. 2021 07 01; 181(7):995-997.
    View in: PubMed
    Score: 0.229
  23. Frequency Of Generic Drug Price Spikes And Impact On Medicaid Spending. Health Aff (Millwood). 2021 05; 40(5):779-785.
    View in: PubMed
    Score: 0.227
  24. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation. Milbank Q. 2021 03; 99(1):240-272.
    View in: PubMed
    Score: 0.224
  25. The Future of Drug-Pricing Transparency. N Engl J Med. 2021 02 11; 384(6):489-491.
    View in: PubMed
    Score: 0.222
  26. Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug Makers. Health Aff (Millwood). 2017 02 01; 36(2):362-370.
    View in: PubMed
    Score: 0.169
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.